Results 71 to 80 of about 51,672 (208)

Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs

open access: yesJournal of Clinical Periodontology, Volume 53, Issue 1, Page 117-126, January 2026.
ABSTRACT Background Periodontitis is a common chronic inflammatory disease. However, drug‐related risks and underlying molecular mechanisms remain underexplored from large real‐world data. Methods We first mined the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to identify drugs disproportionately associated with ...
Wuda Huoshen   +11 more
wiley   +1 more source

Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children’s hospital 22-patient experience

open access: yesPediatric Rheumatology Online Journal, 2020
Background Studies evaluating treatment responses for chronic nonbacterial osteomyelitis (CNO) are lacking. We aimed to measure and compare response rates of medical treatments, time to response of medical treatments among patients with CNO of the ...
Austin Gaal   +3 more
doaj   +1 more source

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma [PDF]

open access: yes, 2015
Bone lytic lesion in Multiple myeloma are the most commonly presented symptoms which require treatment with bisphosphonates (BPs). BPs are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria ...
Alan Archibald (45342)   +21 more
core   +3 more sources

A Case of Extensive Maxillary Medication‐Related Osteonecrosis of the Jaw With Wound Closure Using a Pedicled Buccal Fat Pad

open access: yesCase Reports in Dentistry, Volume 2026, Issue 1, 2026.
Reports of extensive medication‐related osteonecrosis of the jaw (MRONJ) with pedicled buccal fat pad wound closure without tissue reconstruction are rare. We present the case of a 78‐year‐old man with prostate cancer and extensive MRONJ on the left side of the maxilla.
Ryohei Iwasaki   +6 more
wiley   +1 more source

Management of Osteogenesis Imperfecta Complicated by Severe Pneumonia in a Resource‐Limited Setting: A Case Report

open access: yesCase Reports in Pediatrics, Volume 2026, Issue 1, 2026.
Introduction Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by bone fragility, skeletal deformities, and multisystem involvement, with respiratory complications representing a major cause of morbidity and mortality. Intrinsic pulmonary abnormalities, restrictive physiology from scoliosis, and impaired secretion clearance increase
Bipesh Kumar Shah   +7 more
wiley   +1 more source

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report

open access: yesBMC Veterinary Research
Background Pamidronate is used for the treatment of hypercalcemia. However, a rare but potential adverse event of pamidronate treatment is hypocalcemia.
Ye-In Oh   +6 more
doaj   +1 more source

Pharmacodynamics of bisphosphonates in arthritis. [PDF]

open access: yes, 2011
Inflammatory arthritis is a group of autoimmune diseases characterized by chronic inflammation of the joints. Rheumatoid arthritis, the most common form of arthritis, is associated with local joint destruction and systemic bone loss.
Baron   +67 more
core   +1 more source

Use of Zoledronic Acid in the Treatment of Paget's Disease [PDF]

open access: yes, 2011
This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in
Krane, Stephen Martin   +1 more
core  

Pathological mandibular fracture after simple molar extraction in a patient with osteogenesis imperfecta treated with alendronate [PDF]

open access: yes, 2010
Osteogenesis imperfecta (OI), is a heterogeneous group of inherited disorders of connective tissue characterized by bone fragility. Patients with this disease frequently suffer fractures, over 80% of the extremities due to the more intensive mechanical
Costilla García, Serafín   +3 more
core   +1 more source

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases [PDF]

open access: yes, 2017
Background: This phase III study compared the efficacy of the new potent bisphosphonate, ibandronate, with placebo as intravenous (i.v.) therapy in metastatic bone disease due to breast cancer.
Bergström, B.   +7 more
core  

Home - About - Disclaimer - Privacy